Biology Reference
In-Depth Information
Everts V, Aronson DC, Beertsen W (1985) Phagocytosis of bone collagen by osteoclasts in two
cases of pycnodysostosis. Calcif Tissue Int 37:25-31
Everts V, Beertsen W, Schroder R (1988) Effects of the proteinase inhibitors leupeptin and E-64
on osteoclastic bone resorption. Calcif Tissue Int 43:172-178
Everts V, Delaisse JM, Korper W, Beertsen W (1998) Cysteine proteinases and matrix metallo-
proteinases play distinct roles in the subosteoclastic resorption zone. J Bone Miner Res 13:
1420-1430
Everts V, Korper W, Jansen DC et al (1999a) Functional heterogeneity of osteoclasts: matrix
metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption
of long bone. FASEB J 13:1219-1230
Everts V, Korper W, Docherty AJ, Beertsen W (1999b) Matrix metalloproteinase inhibitors block
osteoclastic resorption of calvarial bone but not the resorption of long bone. Ann N Y Acad Sci
878:603-606
Everts V, Delaisse JM, Korper W et al (2002) The bone lining cell: its role in cleaning Howship's
lacunae and initiating bone formation. J Bone Miner Res 17:77-90
Everts V, Hou WS, Rialland X et al (2003) Cathepsin K deficiency in pycnodysostosis results in
accumulation of non-digested phagocytosed collagen in fibroblasts. Calcif Tissue Int 73:
380-386
Everts V, Korper W, Hoeben KA et al (2006) Osteoclastic bone degradation and the role of
different cysteine proteinases and matrix metalloproteinases: differences between calvaria and
long bone. J Bone Miner Res 21:1399-1408
Everts V, Daci E, Tigchelaar-Gutter W et al (2008) Plasminogen activators are involved in the
degradation of bone by osteoclasts. Bone 43:915-920
Everts V, de Vries TJ, Helfrich MH (2009) Osteoclast heterogeneity: lessons from osteopetrosis
and inflammatory conditions. Biochim Biophys Acta 1792:757-765
Fuller K, Chambers TJ (1995) Localisation of mRNA for collagenase in osteocytic, bone surface
and chondrocytic cells but not osteoclasts. J Cell Sci 108(Pt 6):2221-2230
Fuller K, Kirstein B, Chambers TJ (2007) Regulation and enzymatic basis of bone resorption by
human osteoclasts. Clin Sci (Lond) 112:567-575
Gao Y, Morita I, Kubota T, Murota S, Aso T (2000) Expression of adhesion molecules LFA-I and
ICAM-I on osteoclast precursors during osteoclast differentiation and involvement of estrogen
deficiency. Climacteric 3:278-287
Gelb BD, Shi GP, Chapman HA, Desnick RJ (1996) Pycnodysostosis, a lysosomal disease caused
by cathepsin K deficiency. Science 273:1236-1238
Gowen M (1997) Inhibition of cathepsin K-a novel approach to antiresorptive therapy. Expert
Opin Investig Drugs 6:1199-1202
Gowen M, Lazner F, Dodds R et al (1999) Cathepsin K knockout mice develop osteopetrosis due
to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1654-1663
Gu G, Mulari M, Peng Z, Hentunen TA, Vaananen HK (2005) Death of osteocytes turns off the
inhibition of osteoclasts and triggers local bone resorption. Biochem Biophys Res Commun
335:1095-1101
Hall TJ, Chambers TJ (1989) Optimal bone resorption by isolated rat osteoclasts requires chloride/
bicarbonate exchange. Calcif Tissue Int 45:378-380
Halleen JM, Raisanen S, Salo JJ et al (1999) Intracellular fragmentation of bone resorption
products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phospha-
tase. J Biol Chem 274:22907-22910
Halleen JM, Raisanen SR, Alatalo SL, Vaananen HK (2003) Potential function for the ROS-
generating activity of TRACP. J Bone Miner Res 18:1908-1911
Hayman AR, Jones SJ, Boyde A et al (1996) Mice lacking tartrate-resistant acid phosphatase
(Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122:
3151-3162
Helfrich MH (2003) Osteoclast diseases. Microsc Res Tech 61:514-532
